調査レポート | • レポートコード：QYR2104Z2424 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、フォリトロピンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（尿由来卵胞刺激ホルモン、フォリトロピン-α、フォリトロピン-β）、用途別市場規模（不妊治療、生殖補助医療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・フォリトロピンの市場動向 ・企業の競争状況、市場シェア ・フォリトロピンの種類別市場規模（尿由来卵胞刺激ホルモン、フォリトロピン-α、フォリトロピン-β） ・フォリトロピンの用途別市場規模（不妊治療、生殖補助医療） ・フォリトロピンの北米市場規模2016-2027（アメリカ、カナダ） ・フォリトロピンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・フォリトロピンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・フォリトロピンの中南米市場規模2016-2027（メキシコ、ブラジル） ・フォリトロピンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Gedeon Richter、Organon、Ferring、Emd Serono (Merck)、Johnson & Johnson、Solvay、Controlled Therapeutics、Vetter Pharma-Fertigung GmbH&Co. KG、MSD、IBSA、Livzon、Techwell、GenSci、Teva） ・結論 |
Follitropin is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids.
Market Analysis and Insights: Global Follitropin Market
The global Follitropin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Follitropin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Follitropin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Follitropin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Follitropin market.
Global Follitropin Scope and Market Size
Follitropin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Follitropin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Urine-Derived Follicle Stimulating Hormone
Follitropin-α
Follitropin-β
Segment by Application
Infertility Treatment
Assisted Reproductive Technology
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Gedeon Richter
Organon
Ferring
Emd Serono (Merck)
Johnson & Johnson
Solvay
Controlled Therapeutics
Vetter Pharma-Fertigung GmbH&Co. KG
MSD
IBSA
Livzon
Techwell
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Follitropin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Urine-Derived Follicle Stimulating Hormone
1.2.3 Follitropin-α
1.2.4 Follitropin-β
1.3 Market by Application
1.3.1 Global Follitropin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Follitropin Market Perspective (2016-2027)
2.2 Follitropin Growth Trends by Regions
2.2.1 Follitropin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Follitropin Historic Market Share by Regions (2016-2021)
2.2.3 Follitropin Forecasted Market Size by Regions (2022-2027)
2.3 Follitropin Industry Dynamic
2.3.1 Follitropin Market Trends
2.3.2 Follitropin Market Drivers
2.3.3 Follitropin Market Challenges
2.3.4 Follitropin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Follitropin Players by Revenue
3.1.1 Global Top Follitropin Players by Revenue (2016-2021)
3.1.2 Global Follitropin Revenue Market Share by Players (2016-2021)
3.2 Global Follitropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Follitropin Revenue
3.4 Global Follitropin Market Concentration Ratio
3.4.1 Global Follitropin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Follitropin Revenue in 2020
3.5 Follitropin Key Players Head office and Area Served
3.6 Key Players Follitropin Product Solution and Service
3.7 Date of Enter into Follitropin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Follitropin Breakdown Data by Type
4.1 Global Follitropin Historic Market Size by Type (2016-2021)
4.2 Global Follitropin Forecasted Market Size by Type (2022-2027)
5 Follitropin Breakdown Data by Application
5.1 Global Follitropin Historic Market Size by Application (2016-2021)
5.2 Global Follitropin Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Follitropin Market Size (2016-2027)
6.2 North America Follitropin Market Size by Type
6.2.1 North America Follitropin Market Size by Type (2016-2021)
6.2.2 North America Follitropin Market Size by Type (2022-2027)
6.2.3 North America Follitropin Market Size by Type (2016-2027)
6.3 North America Follitropin Market Size by Application
6.3.1 North America Follitropin Market Size by Application (2016-2021)
6.3.2 North America Follitropin Market Size by Application (2022-2027)
6.3.3 North America Follitropin Market Size by Application (2016-2027)
6.4 North America Follitropin Market Size by Country
6.4.1 North America Follitropin Market Size by Country (2016-2021)
6.4.2 North America Follitropin Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Follitropin Market Size (2016-2027)
7.2 Europe Follitropin Market Size by Type
7.2.1 Europe Follitropin Market Size by Type (2016-2021)
7.2.2 Europe Follitropin Market Size by Type (2022-2027)
7.2.3 Europe Follitropin Market Size by Type (2016-2027)
7.3 Europe Follitropin Market Size by Application
7.3.1 Europe Follitropin Market Size by Application (2016-2021)
7.3.2 Europe Follitropin Market Size by Application (2022-2027)
7.3.3 Europe Follitropin Market Size by Application (2016-2027)
7.4 Europe Follitropin Market Size by Country
7.4.1 Europe Follitropin Market Size by Country (2016-2021)
7.4.2 Europe Follitropin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Follitropin Market Size (2016-2027)
8.2 Asia-Pacific Follitropin Market Size by Type
8.2.1 Asia-Pacific Follitropin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Follitropin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Follitropin Market Size by Type (2016-2027)
8.3 Asia-Pacific Follitropin Market Size by Application
8.3.1 Asia-Pacific Follitropin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Follitropin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Follitropin Market Size by Application (2016-2027)
8.4 Asia-Pacific Follitropin Market Size by Region
8.4.1 Asia-Pacific Follitropin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Follitropin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Follitropin Market Size (2016-2027)
9.2 Latin America Follitropin Market Size by Type
9.2.1 Latin America Follitropin Market Size by Type (2016-2021)
9.2.2 Latin America Follitropin Market Size by Type (2022-2027)
9.2.3 Latin America Follitropin Market Size by Type (2016-2027)
9.3 Latin America Follitropin Market Size by Application
9.3.1 Latin America Follitropin Market Size by Application (2016-2021)
9.3.2 Latin America Follitropin Market Size by Application (2022-2027)
9.3.3 Latin America Follitropin Market Size by Application (2016-2027)
9.4 Latin America Follitropin Market Size by Country
9.4.1 Latin America Follitropin Market Size by Country (2016-2021)
9.4.2 Latin America Follitropin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Follitropin Market Size (2016-2027)
10.2 Middle East & Africa Follitropin Market Size by Type
10.2.1 Middle East & Africa Follitropin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Follitropin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Follitropin Market Size by Type (2016-2027)
10.3 Middle East & Africa Follitropin Market Size by Application
10.3.1 Middle East & Africa Follitropin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Follitropin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Follitropin Market Size by Application (2016-2027)
10.4 Middle East & Africa Follitropin Market Size by Country
10.4.1 Middle East & Africa Follitropin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Follitropin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Gedeon Richter
11.1.1 Gedeon Richter Company Details
11.1.2 Gedeon Richter Business Overview
11.1.3 Gedeon Richter Follitropin Introduction
11.1.4 Gedeon Richter Revenue in Follitropin Business (2016-2021)
11.1.5 Gedeon Richter Recent Development
11.2 Organon
11.2.1 Organon Company Details
11.2.2 Organon Business Overview
11.2.3 Organon Follitropin Introduction
11.2.4 Organon Revenue in Follitropin Business (2016-2021)
11.2.5 Organon Recent Development
11.3 Ferring
11.3.1 Ferring Company Details
11.3.2 Ferring Business Overview
11.3.3 Ferring Follitropin Introduction
11.3.4 Ferring Revenue in Follitropin Business (2016-2021)
11.3.5 Ferring Recent Development
11.4 Emd Serono (Merck)
11.4.1 Emd Serono (Merck) Company Details
11.4.2 Emd Serono (Merck) Business Overview
11.4.3 Emd Serono (Merck) Follitropin Introduction
11.4.4 Emd Serono (Merck) Revenue in Follitropin Business (2016-2021)
11.4.5 Emd Serono (Merck) Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Follitropin Introduction
11.5.4 Johnson & Johnson Revenue in Follitropin Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Solvay
11.6.1 Solvay Company Details
11.6.2 Solvay Business Overview
11.6.3 Solvay Follitropin Introduction
11.6.4 Solvay Revenue in Follitropin Business (2016-2021)
11.6.5 Solvay Recent Development
11.7 Controlled Therapeutics
11.7.1 Controlled Therapeutics Company Details
11.7.2 Controlled Therapeutics Business Overview
11.7.3 Controlled Therapeutics Follitropin Introduction
11.7.4 Controlled Therapeutics Revenue in Follitropin Business (2016-2021)
11.7.5 Controlled Therapeutics Recent Development
11.8 Vetter Pharma-Fertigung GmbH&Co. KG
11.8.1 Vetter Pharma-Fertigung GmbH&Co. KG Company Details
11.8.2 Vetter Pharma-Fertigung GmbH&Co. KG Business Overview
11.8.3 Vetter Pharma-Fertigung GmbH&Co. KG Follitropin Introduction
11.8.4 Vetter Pharma-Fertigung GmbH&Co. KG Revenue in Follitropin Business (2016-2021)
11.8.5 Vetter Pharma-Fertigung GmbH&Co. KG Recent Development
11.9 MSD
11.9.1 MSD Company Details
11.9.2 MSD Business Overview
11.9.3 MSD Follitropin Introduction
11.9.4 MSD Revenue in Follitropin Business (2016-2021)
11.9.5 MSD Recent Development
11.10 IBSA
11.10.1 IBSA Company Details
11.10.2 IBSA Business Overview
11.10.3 IBSA Follitropin Introduction
11.10.4 IBSA Revenue in Follitropin Business (2016-2021)
11.10.5 IBSA Recent Development
11.11 Livzon
11.11.1 Livzon Company Details
11.11.2 Livzon Business Overview
11.11.3 Livzon Follitropin Introduction
11.11.4 Livzon Revenue in Follitropin Business (2016-2021)
11.11.5 Livzon Recent Development
11.12 Techwell
11.12.1 Techwell Company Details
11.12.2 Techwell Business Overview
11.12.3 Techwell Follitropin Introduction
11.12.4 Techwell Revenue in Follitropin Business (2016-2021)
11.12.5 Techwell Recent Development
11.13 GenSci
11.13.1 GenSci Company Details
11.13.2 GenSci Business Overview
11.13.3 GenSci Follitropin Introduction
11.13.4 GenSci Revenue in Follitropin Business (2016-2021)
11.13.5 GenSci Recent Development
11.14 Teva
11.14.1 Teva Company Details
11.14.2 Teva Business Overview
11.14.3 Teva Follitropin Introduction
11.14.4 Teva Revenue in Follitropin Business (2016-2021)
11.14.5 Teva Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Follitropin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Urine-Derived Follicle Stimulating Hormone
Table 3. Key Players of Follitropin-α
Table 4. Key Players of Follitropin-β
Table 5. Global Follitropin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Follitropin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Follitropin Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Follitropin Market Share by Regions (2016-2021)
Table 9. Global Follitropin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Follitropin Market Share by Regions (2022-2027)
Table 11. Follitropin Market Trends
Table 12. Follitropin Market Drivers
Table 13. Follitropin Market Challenges
Table 14. Follitropin Market Restraints
Table 15. Global Follitropin Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Follitropin Market Share by Players (2016-2021)
Table 17. Global Top Follitropin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follitropin as of 2020)
Table 18. Ranking of Global Top Follitropin Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Follitropin Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Follitropin Product Solution and Service
Table 22. Date of Enter into Follitropin Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Follitropin Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Follitropin Revenue Market Share by Type (2016-2021)
Table 26. Global Follitropin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Follitropin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Follitropin Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Follitropin Revenue Market Share by Application (2016-2021)
Table 30. Global Follitropin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Follitropin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Follitropin Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Follitropin Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Follitropin Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Follitropin Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Follitropin Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Follitropin Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Follitropin Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Follitropin Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Follitropin Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Follitropin Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Follitropin Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Follitropin Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Follitropin Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Follitropin Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Follitropin Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Follitropin Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Follitropin Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Follitropin Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Follitropin Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Follitropin Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Follitropin Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Follitropin Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Follitropin Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Follitropin Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Follitropin Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Follitropin Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Follitropin Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Follitropin Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Follitropin Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Follitropin Market Size by Country (2022-2027) & (US$ Million)
Table 62. Gedeon Richter Company Details
Table 63. Gedeon Richter Business Overview
Table 64. Gedeon Richter Follitropin Product
Table 65. Gedeon Richter Revenue in Follitropin Business (2016-2021) & (US$ Million)
Table 66. Gedeon Richter Recent Development
Table 67. Organon Company Details
Table 68. Organon Business Overview
Table 69. Organon Follitropin Product
Table 70. Organon Revenue in Follitropin Business (2016-2021) & (US$ Million)
Table 71. Organon Recent Development
Table 72. Ferring Company Details
Table 73. Ferring Business Overview
Table 74. Ferring Follitropin Product
Table 75. Ferring Revenue in Follitropin Business (2016-2021) & (US$ Million)
Table 76. Ferring Recent Development
Table 77. Emd Serono (Merck) Company Details
Table 78. Emd Serono (Merck) Business Overview
Table 79. Emd Serono (Merck) Follitropin Product
Table 80. Emd Serono (Merck) Revenue in Follitropin Business (2016-2021) & (US$ Million)
Table 81. Emd Serono (Merck) Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Follitropin Product
Table 85. Johnson & Johnson Revenue in Follitropin Business (2016-2021) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. Solvay Company Details
Table 88. Solvay Business Overview
Table 89. Solvay Follitropin Product
Table 90. Solvay Revenue in Follitropin Business (2016-2021) & (US$ Million)
Table 91. Solvay Recent Development
Table 92. Controlled Therapeutics Company Details
Table 93. Controlled Therapeutics Business Overview
Table 94. Controlled Therapeutics Follitropin Product
Table 95. Controlled Therapeutics Revenue in Follitropin Business (2016-2021) & (US$ Million)
Table 96. Controlled Therapeutics Recent Development
Table 97. Vetter Pharma-Fertigung GmbH&Co. KG Company Details
Table 98. Vetter Pharma-Fertigung GmbH&Co. KG Business Overview
Table 99. Vetter Pharma-Fertigung GmbH&Co. KG Revenue in Follitropin Business (2016-2021) & (US$ Million)
Table 100. Vetter Pharma-Fertigung GmbH&Co. KG Recent Development
Table 101. MSD Company Details
Table 102. MSD Business Overview
Table 103. MSD Follitropin Product
Table 104. MSD Revenue in Follitropin Business (2016-2021) & (US$ Million)
Table 105. MSD Recent Development
Table 106. IBSA Company Details
Table 107. IBSA Business Overview
Table 108. IBSA Follitropin Product
Table 109. IBSA Revenue in Follitropin Business (2016-2021) & (US$ Million)
Table 110. IBSA Recent Development
Table 111. Livzon Company Details
Table 112. Livzon Business Overview
Table 113. Livzon Follitropin Product
Table 114. Livzon Revenue in Follitropin Business (2016-2021) & (US$ Million)
Table 115. Livzon Recent Development
Table 116. Techwell Company Details
Table 117. Techwell Business Overview
Table 118. Techwell Follitropin Product
Table 119. Techwell Revenue in Follitropin Business (2016-2021) & (US$ Million)
Table 120. Techwell Recent Development
Table 121. GenSci Company Details
Table 122. GenSci Business Overview
Table 123. GenSci Follitropin Product
Table 124. GenSci Revenue in Follitropin Business (2016-2021) & (US$ Million)
Table 125. GenSci Recent Development
Table 126. Teva Company Details
Table 127. Teva Business Overview
Table 128. Teva Follitropin Product
Table 129. Teva Revenue in Follitropin Business (2016-2021) & (US$ Million)
Table 130. Teva Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Follitropin Market Share by Type: 2020 VS 2027
Figure 2. Urine-Derived Follicle Stimulating Hormone Features
Figure 3. Follitropin-α Features
Figure 4. Follitropin-β Features
Figure 5. Global Follitropin Market Share by Application: 2020 VS 2027
Figure 6. Infertility Treatment Case Studies
Figure 7. Assisted Reproductive Technology Case Studies
Figure 8. Follitropin Report Years Considered
Figure 9. Global Follitropin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Follitropin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Follitropin Market Share by Regions: 2020 VS 2027
Figure 12. Global Follitropin Market Share by Regions (2022-2027)
Figure 13. Global Follitropin Market Share by Players in 2020
Figure 14. Global Top Follitropin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follitropin as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Follitropin Revenue in 2020
Figure 16. Global Follitropin Revenue Market Share by Type (2016-2021)
Figure 17. Global Follitropin Revenue Market Share by Type (2022-2027)
Figure 18. North America Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Follitropin Market Share by Type (2016-2027)
Figure 20. North America Follitropin Market Share by Application (2016-2027)
Figure 21. North America Follitropin Market Share by Country (2016-2027)
Figure 22. United States Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Follitropin Market Share by Type (2016-2027)
Figure 26. Europe Follitropin Market Share by Application (2016-2027)
Figure 27. Europe Follitropin Market Share by Country (2016-2027)
Figure 28. Germany Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Follitropin Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Follitropin Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Follitropin Market Share by Region (2016-2027)
Figure 38. China Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Follitropin Market Share by Type (2016-2027)
Figure 46. Latin America Follitropin Market Share by Application (2016-2027)
Figure 47. Latin America Follitropin Market Share by Country (2016-2027)
Figure 48. Mexico Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Follitropin Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Follitropin Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Follitropin Market Share by Country (2016-2027)
Figure 54. Turkey Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Follitropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Gedeon Richter Revenue Growth Rate in Follitropin Business (2016-2021)
Figure 58. Organon Revenue Growth Rate in Follitropin Business (2016-2021)
Figure 59. Ferring Revenue Growth Rate in Follitropin Business (2016-2021)
Figure 60. Emd Serono (Merck) Revenue Growth Rate in Follitropin Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Follitropin Business (2016-2021)
Figure 62. Solvay Revenue Growth Rate in Follitropin Business (2016-2021)
Figure 63. Controlled Therapeutics Revenue Growth Rate in Follitropin Business (2016-2021)
Figure 64. Vetter Pharma-Fertigung GmbH&Co. KG Revenue Growth Rate in Follitropin Business (2016-2021)
Figure 65. MSD Revenue Growth Rate in Follitropin Business (2016-2021)
Figure 66. IBSA Revenue Growth Rate in Follitropin Business (2016-2021)
Figure 67. Livzon Revenue Growth Rate in Follitropin Business (2016-2021)
Figure 68. Techwell Revenue Growth Rate in Follitropin Business (2016-2021)
Figure 69. GenSci Revenue Growth Rate in Follitropin Business (2016-2021)
Figure 70. Teva Revenue Growth Rate in Follitropin Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の生殖補助技術（ART）市場規模・現状・予測（2021年-2027年） Assisted Reproductive Technology (ART) is the technology used to achieve pregnancy in procedures such as fertility medication, in vitro fertilization and surrogacy. It is reproductive technology used primarily for infertility treatments, and is also known as fertility treatment. It mainly belongs to…- 世界の生殖補助技術（ART）市場規模・現状・予測（2021年-2027年） Assisted reproductive technology (ART) is a wide range of procedures that are used to treat infertility in men and women. Generally, ART procedures include techniques, such as IVF, ZIFT, GIFT, ICSI, and artificial insemination, which help individuals to conceive a child. The analysts forecast the gl…
- 世界の生殖ホルモン市場規模・現状・予測（2021年-2027年） Reproductive hormones are usually made in the ovaries (in females) and testes (in males)，which use to helping develop and maintain female and male sex characteristics and play an important role in the menstrual cycle, fertility, and pregnancy. Globally, the reproductive hormone industry market is re…
- 世界の男性不妊症診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Male Infertility Diagnosis and Treatment Market The global Male Infertility Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analys…
- 世界の女性不妊症診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Female Infertility Diagnosis and Treatment Market The global Female Infertility Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in an…